Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DF Medical Ventures is a private investment firm specializing in the healthcare and medical technology sectors, with a primary focus on innovative medical devices and robotic surgical systems. Led by David Fischel, who also serves as the Chairman and CEO of Stereotaxis, the firm is a major stakeholder in companies developing advanced navigation and signal processing technologies for cardiac procedures. DF Medical Ventures is most recognized for its strategic involvement in Stereotaxis, where it has provided capital and leadership to drive the commercialization of robotic magnetic navigation systems. The firm emphasizes long-term value creation by supporting high-impact clinical technologies that improve the precision and safety of complex medical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DF Medical Ventures.